Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2006 1
2010 2
2011 1
2012 1
2013 2
2014 4
2015 3
2016 1
2017 1
2018 1
2019 4
2020 3
2021 4
2022 3
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial.
Richardson PG, Oriol A, Beksac M, Liberati AM, Galli M, Schjesvold F, Lindsay J, Weisel K, White D, Facon T, San Miguel J, Sunami K, O'Gorman P, Sonneveld P, Robak P, Semochkin S, Schey S, Yu X, Doerr T, Bensmaine A, Biyukov T, Peluso T, Zaki M, Anderson K, Dimopoulos M; OPTIMISMM trial investigators. Richardson PG, et al. Lancet Oncol. 2019 Jun;20(6):781-794. doi: 10.1016/S1470-2045(19)30152-4. Epub 2019 May 13. Lancet Oncol. 2019. PMID: 31097405 Clinical Trial.
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.
Mateos MV, Dimopoulos MA, Cavo M, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Kaplan P, Pour L, Cook M, Grosicki S, Crepaldi A, Liberati AM, Campbell P, Shelekhova T, Yoon SS, Iosava G, Fujisaki T, Garg M, Chiu C, Wang J, Carson R, Crist W, Deraedt W, Nguyen H, Qi M, San-Miguel J; ALCYONE Trial Investigators. Mateos MV, et al. Among authors: lucio p. N Engl J Med. 2018 Feb 8;378(6):518-528. doi: 10.1056/NEJMoa1714678. Epub 2017 Dec 12. N Engl J Med. 2018. PMID: 29231133 Free article. Clinical Trial.
Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial.
Mateos MV, Cavo M, Blade J, Dimopoulos MA, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Pour L, Cook M, Grosicki S, Crepaldi A, Liberati AM, Campbell P, Shelekhova T, Yoon SS, Iosava G, Fujisaki T, Garg M, Krevvata M, Chen Y, Wang J, Kudva A, Ukropec J, Wroblewski S, Qi M, Kobos R, San-Miguel J. Mateos MV, et al. Among authors: lucio p. Lancet. 2020 Jan 11;395(10218):132-141. doi: 10.1016/S0140-6736(19)32956-3. Epub 2019 Dec 10. Lancet. 2020. PMID: 31836199 Clinical Trial.
[Multiple Myeloma Treatment Guidelines by the Portuguese Group of Multiple Myeloma].
João C, Bergantim R, Santos J, Afonso C, Bernardo P, Coelho H, Costa C, Esteves G, Freitas JG, Gerivaz R, Jorge A, Macedo A, Montalvão A, Neves M, Pedrosa CL, Pereira S, Roque A, Seabra P, M Silva H, Silveira MP, Tomé A, Trigo F, Sarmento AB, Lúcio P, Geraldes C; GRUPO PORTUGUÊS DO MIELOMA MÚLTIPLO. João C, et al. Among authors: lucio p. Acta Med Port. 2023 Jul 3;36(7-8):517-526. doi: 10.20344/amp.19037. Epub 2023 Jul 3. Acta Med Port. 2023. PMID: 37429590 Free article. Portuguese.
Imputation of precipitation data in northeast Brazil.
Rodrigues DT, Gonçalves WA, Silva CMSE, Spyrides MHC, Lúcio PS. Rodrigues DT, et al. Among authors: lucio ps. An Acad Bras Cienc. 2023 Jun 5;95(2):e20210737. doi: 10.1590/0001-3765202320210737. eCollection 2023. An Acad Bras Cienc. 2023. PMID: 37283329 Free article.
Summary of the first Brazilian Symposium on Human Biometeorology.
Krüger EL, Dos Santos Gomes AC, Lucio PS, Gobo JPA, Nedel AS, Gonçalves FLT, Piacenti-Silva M, Di Napoli C, Lam CKC. Krüger EL, et al. Among authors: lucio ps. Int J Biometeorol. 2023 Feb;67(2):405-408. doi: 10.1007/s00484-022-02401-3. Epub 2022 Nov 1. Int J Biometeorol. 2023. PMID: 36316403
Multiple Myeloma in Portugal: Burden of Disease and Cost of Illness.
Neves M, Trigo F, Rui B, João C, Lúcio P, Mariana N, Mendes J, Pedrosa H, Geraldes C. Neves M, et al. Among authors: lucio p. Pharmacoeconomics. 2021 May;39(5):579-587. doi: 10.1007/s40273-020-00993-5. Epub 2021 Jan 31. Pharmacoeconomics. 2021. PMID: 33517511 Free PMC article.
36 results